Hematopoietic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Hematopoietic Agents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Pharmaceutical

Report Description

1
1

Hematopoiesis is a process of continuous replacement of most mature blood cells. New produced blood cells must be adequate to meet the basic demand of body. Hematopoiesis process needs an ample supply of minerals (e.g., iron, copper, and cobalt) and vitamins (e.g., vitamin B12, folic acid, ascorbic acid, pyridoxine, and riboflavin). Normal hematopoiesis process produces more than 400 billion blood cells each day, this production can be increased several-fold with increased demand by hematopoietic agents. If hematopoiesis slowdowns or any disorder occurs which results in a deficiency of normal blood cells which is lead to anemia, thrombocytopenia or neutropenia. Hematopoietic agents Market are intended to improve the quality and quantity of the blood, by increasing the hemoglobin level and the number of erythrocytes leucocytes and platelets. Hematopoietic agents Market are mostly used in the in the treatment of anemia. Exhaustion and tiredness, headache, dyspnoea, dry and rough skin, tachycardia, restless legs syndrome, neurocognitive dysfunction, hemodynamic instability, brittle nails or hair loss, and yellow sallow skin are the major symptoms of hematopoiesis disorder. 

Increasing the risk of haemodilution in pregnancy drive the hematopoietic agents market. Changes in lifestyle are playing a major role in propelling the global hematopoietic agents market. According to National Heart, Lung, and Blood Institute (NHLBI) report, an estimated 20% women of childbearing age have iron-deficiency anemia. Rapid or irregular heartbeat due to low amount oxygen blood leads to major complications such as heart failure or an enlarged heart. Additionally, Availability of large patient pool, expansion of the health care industry, and rise in various country's government investment to improve health care are anticipated to propel the market. High cost, high competition among existing players, stringent government regulation for approval of the product and lack of awareness are key restraints of the market.

The global hematopoietic agents market is can be segmented based on, application, distribution channel, and region. In terms of application, the global hematopoietic agents market can be divided into anemia, thrombocytopenia, neutropenia, cancer treatment, marrow transplantation and others blood disorders. According to World Health Organization, in 2011 estimates that anemia affects around 800 million children and women globally. The cancer segment is likely to expand at the fastest growth rate during the forecast period from 2017 to 2025. Based on distribution channel, the global hematopoietic agents market can be categorized into hospitals pharmacies, retail pharmacies, dietary care centers and others. Rising prevalence of hematological disorders likely to boost the market in the near future.

In terms of region, the global hematopoietic agents market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the largest market for hematopoietic agents, followed by Europe and Asia Pacific. The U.S. is a major contributor to the hematopoietic agents market in North America in terms of revenue. The market in Asia Pacific is expanding rapidly due to increase in a number of patients. However, Asia Pacific and Africa are projected to be the most attractive markets in the near future, especially emerging economies such as such as Brazil, India, China, and Japan, due to its better health care infrastructure, economic growth, expanding and developing private health care sector, improving insurance payers, and increasing awareness among population.

Key players in the global hematopoietic agents market include Amgen Inc., Apotex, Luitpold Pharmaceuticals Inc., Novartis AG, AMAG Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Acceleron Pharma, Inc., F. Hoffmann-La Roche Ltd, Bayer AG, Johnson & Johnson, Akebia Therapeutics, Inc., Pfizer Inc.,  Pharmacosmos A/S. and others

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074